Russia Over-the-counter (OTC) Drugs Industry Outlook to 2017

Driven by Rising Ageing Population

Region:Europe

Product Code:KR119

Download Sample Report

Published On

January 2014

Total pages

Table of Content

Market Overview
Scope Of The Report
Product covered
Table Of Content
Research Methodology
FAQs

Download Sample Report

About the Report

The report titled "Russia Over-the-counter (OTC) Drugs Industry Outlook to 2017- Driven by Rising Ageing Population" presents a comprehensive analysis of the industry covering aspects including market size by revenue and by volume and market segmentation by cold and cough medications, analgesics, digestives, skin treatment products, vitamin and mineral supplements and others. The report also entails a detailed description on the recent trends and developments in the market in and competitive scenario of major players in the industry along with providing market share of major companies in the overall market and market share of major drugs in each category.

The OTC drugs market in Russia has emerged as the fastest growing sectors of the pharmaceutical market in Central and Eastern European region due to its low cost manufacturing. The market has registered a CAGR of 10.3% during 2006-2012 by rising from USD ~ million in 2006 to USD ~ million in 2012.

Cold and cough medications commanded the largest share of ~% share of the total OTC drugs sales in the country in 2012 which has risen from ~% in 2006 followed by Digestives which grew from USD ~ million in 2006 to USD ~ million in 2012. Analgesics have also showcased double digit growth rate in terms of the market revenue and has risen its share from ~% in 2010 to ~% in 2012. Around USD ~ million worth vitamins and minerals were sold in the Russian market in 2012, thereby registering a strong CAGR of 12.9% over the period 2006-2012.

Moscow accounted for the highest share of ~% of the total sales of OTC drugs in Russia in 2012, followed by Saint Petersburg which accounted for ~% of the OTC drugs sales in the country during the year.

Pharmstandard is the largest company with a market share of ~%. The revenue from the sales of OTC drugs by the company was recorded as USD ~ million in 2012 as compared to USD ~ million in 2011. Sanofi Aventis is the second largest OTC drugs company Russia recorded a market share of ~% in 1H2013 followed by Sandoz and Bayer holding nearly ~% in the market.

The anti cold and flu drugs market in Russia was primarily led by aribdol, which was the category leader in anti cold and flu drugs in Russia in 2012 with a market share of ~% followed by Theraflu of Novartis accounting for a share of ~% in the market in 2012. Multivitamins with minerals market in Russia is majorly tapped by Vitrum drug supplied by unipharm with a market share of ~% in 2012.

The future of the Russia is expected to be favorable on account of rapidly growing elderly population; rising obesity and a large number of smokers who will contribute to the demand for over the counter drugs in Russia in the future. The market is projected to reach USD ~ million by 2017.

KEY TOPICS COVERED IN THE REPORT

- Market Size of Russia OTC Drugs Market by Revenue, 2006-2012

- Market Size of Russia OTC Drugs Market by Volume, 2008-2012

- Market Segmentation of Russia OTC Drugs Market by Key Product Categories, 2006-2012

- Market Segmentation of Russia OTC Drugs Market by major City wise sales value, 2012

- Trends and Developments in Russia OTC Drugs Market

- Government Regulations in the OTC Drugs Market in Russia

- Market Share of Major Players in OTC drugs market in Russia

- Market Share of Major brands in key product categories of OTC drugs

- Future Outlook and Projections in Russia OTC Drugs Market

Products

cold and cough medications, analgesics, digestives, skin treatment products, vitamin and mineral supplements, non-prescription drugs, OTC Drugs, Over

Companies

Arbidol (Pharmstandard), Theraflu (Novartis), Kagocel (Niamedik Plus), Anaferon (Materia Medika), Oscillococcinum (Laboratoire Boiron), Coldrex (GSK), Antigrippin (Anti viral Natur Product), Viferon (Feron), Coldrex (GSK), Amixin (Pharmstandard), Fervek

1. Central and Eastern Europe OTC Drugs Market Introduction

1.1. Central and Eastern Europe OTC Drugs Market Size by Revenue, 2006-2012

2. Russia OTC Drugs Market Introduction

3. Russia OTC Drugs Market Size, 2006-2012

3.1. By Revenue, 2006-2012

3.2. By Volume, 2008-2012

4. Russia OTC Drugs Market Segmentation, 2006-2012

4.1. By Cold and Cough, Analgesics, Digestives, Skin Products, Vitamins and Minerals and Others, 2006-2012

4.2. By Cities, 2012

5. Trends and Developments in Russia OTC Drugs Market

Approval of Selling of OTC Drugs in retail stores by Ministry of Healthcare

Appointment of New Government: Spurring Developments in Health Sector in Russia

Increasing Focus on Bio-Additives and Functional Nutrition

6. Government Regulations in Russia OTC Drugs Industry

Ban on Over the Counter Sales of Medical Drugs

Major Regulatory Changes in Russian Pharmaceutical Market in 2012

7. Market Share of Major Players in Russia OTC Drugs Market, 1H2013

7.1. By Anti Cold and Flu Drugs, 2012

7.2. By Non- Narcotic Analgesics and Antipyretic Drugs, 2012

7.3. By Expectorants & Antitussives (Cough Medications), 2012

7.4. By Multivitamins with Minerals, 2012

7.5. By Systematic Agents for Fungal Infections, 2012

8. Competitive Landscape of Major Players in Russia OTC Drugs Market

9. Russia OTC Drugs Market Future Outlook and Projections, 2013-2017

10. Macro Economic Factors of Russia OTC Drugs Market: Historical and Projected

10.1. Population, 2006-2017

10.2. Public and Private Health Expenditure, 2006-2017

10.3. Consumer Price Index on Medicines, 2010-2012

11. Appendix

11.1. Market Definitions

11.2. Abbreviations

11.3. Research Methodology

Data Collection Methods

Approach

Variables (Dependent and Independent)

Multi Factor Based Sensitivity Model

Final Conclusion

11.4. Disclaimer

Why Buy From Us?

Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository

150+ Consulting project a year

100+ Analysts

8000+ Client Queries in 2022